Ketorolac Tromethamine Market

Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.
Ketorolac Tromethamine Market contains market size and forecasts of Ketorolac Tromethamine in global, including the following market information:
Global Ketorolac Tromethamine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ketorolac Tromethamine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Ketorolac Tromethamine companies in 2021 (%)
The global Ketorolac Tromethamine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ketorolac Tromethamine include Pfizer, Omeros Corporation, Egalet US Inc., Allergan, Dr. Reddy?s Laboratories, Teva, Mylan, West Ward Pharmaceuticals and Fresenius Kabi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ketorolac Tromethamine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ketorolac Tromethamine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ketorolac Tromethamine Market Segment Percentages, by Type, 2021 (%)
Injection
Ophthalmic
Nasal
Oral tablet
Global Ketorolac Tromethamine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ketorolac Tromethamine Market Segment Percentages, by Application, 2021 (%)
Short-term treatment of pain
Ophthalmic Surgery
Global Ketorolac Tromethamine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ketorolac Tromethamine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ketorolac Tromethamine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ketorolac Tromethamine revenues share in global market, 2021 (%)
Key companies Ketorolac Tromethamine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Ketorolac Tromethamine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Omeros Corporation
Egalet US Inc.
Allergan
Dr. Reddy?s Laboratories
Teva
Mylan
West Ward Pharmaceuticals
Fresenius Kabi
Apotex
Sandoz
Amphastar Pharmaceuticals
Gland Pharma Limited
Akorn
Sun Pharmaceutical
Sagent Pharmaceuticals
Aurobindo Pharma